AMPERA Trademark

Trademark Overview

On Friday, September 15, 2017, a trademark application was filed for AMPERA with the United States Patent and Trademark Office. The USPTO has given the AMPERA trademark a serial number of 87610403. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 27, 2021. This trademark is owned by ACORDA THERAPEUTICS, INC.,. The AMPERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological or musculoskeletal diseases, disorders and conditions; Pharmaceutical products, namely, pharmaceutical and biological preparations and formulations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological or musculoskeletal diseases, disorders and conditions
ampera

General Information

Serial Number87610403
Word MarkAMPERA
Filing DateFriday, September 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological or musculoskeletal diseases, disorders and conditions; Pharmaceutical products, namely, pharmaceutical and biological preparations and formulations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological or musculoskeletal diseases, disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACORDA THERAPEUTICS, INC.,
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameACORDA THERAPEUTICS, INC.,
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Monday, December 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 23, 2021EXTENSION 5 GRANTED
Wednesday, May 5, 2021EXTENSION 5 FILED
Tuesday, June 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 5, 2021TEAS EXTENSION RECEIVED
Wednesday, November 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 16, 2020EXTENSION 4 GRANTED
Monday, November 16, 2020EXTENSION 4 FILED
Monday, November 16, 2020TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 10, 2020EXTENSION 3 GRANTED
Sunday, May 10, 2020EXTENSION 3 FILED
Sunday, May 10, 2020TEAS EXTENSION RECEIVED
Friday, November 15, 2019EARLY EXTENSION OF USE REFUSED
Friday, November 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2019TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019EXTENSION 2 GRANTED
Tuesday, November 12, 2019EXTENSION 2 FILED
Tuesday, November 12, 2019TEAS EXTENSION RECEIVED
Tuesday, May 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2019EXTENSION 1 GRANTED
Friday, May 17, 2019EXTENSION 1 FILED
Friday, May 17, 2019TEAS EXTENSION RECEIVED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, February 27, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 3, 2018ASSIGNED TO LIE
Thursday, January 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 19, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 19, 2017ASSIGNED TO EXAMINER
Thursday, September 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 19, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ampera pharmaceutical neurological other musculoskeletal diseases conditions disorders multiple sclerosis preparations